KRT77

gene
On this page

Summary

KRT77 (keratin 77, HGNC:20411) is a protein-coding gene on chromosome 12q13.13, encoding Keratin, type II cytoskeletal 1b (Q7Z794).

Keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into epithelial keratins and hair keratins. This gene encodes an epithelial keratin that is expressed in the skin and eccrine sweat glands. The type II keratins are clustered in a region of chromosome 12q13.

Source: NCBI Gene 374454 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 103 total
  • MANE Select transcript: NM_175078

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20411
Approved symbolKRT77
Namekeratin 77
Location12q13.13
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000189182
Ensembl biotypeprotein_coding
OMIM611158
Entrez374454

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 1 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay

ENST00000341809, ENST00000550823, ENST00000553168

RefSeq mRNA: 1 — MANE Select: NM_175078 NM_175078

CCDS: CCDS8837

Canonical transcript exons

ENST00000341809 — 9 exons

ExonStartEnd
ENSE000013788065268962652691439
ENSE000034998065269768252697896
ENSE000035121305269462652694790
ENSE000035444345269275552692880
ENSE000035539415269577252695867
ENSE000035754235269193852691972
ENSE000036364215269637052696430
ENSE000036451745269242152692641
ENSE000038952415270289252703524

Expression profiles

Bgee: expression breadth ubiquitous, 102 present calls, max score 99.74.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1140 / max 94.9929, expressed in 9 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1311220.11409

Top tissues by expression

235 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
upper arm skinUBERON:000426399.74gold quality
upper leg skinUBERON:000426299.44gold quality
nippleUBERON:000203098.84gold quality
skin of hipUBERON:000155498.65gold quality
skin of abdomenUBERON:000141698.09gold quality
zone of skinUBERON:000001497.43gold quality
skin of legUBERON:000151196.93gold quality
mammalian vulvaUBERON:000099779.88gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047379.26gold quality
pancreatic ductal cellCL:000207973.50silver quality
tibialis anteriorUBERON:000138570.98silver quality
penisUBERON:000098969.64gold quality
ileal mucosaUBERON:000033169.62silver quality
deltoidUBERON:000147659.03gold quality
lower esophagus mucosaUBERON:003583457.69gold quality
epithelial cell of pancreasCL:000008356.29gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099155.82gold quality
cardiac muscle of right atriumUBERON:000337954.34gold quality
left ventricle myocardiumUBERON:000656654.23gold quality
kidney epitheliumUBERON:000481953.93gold quality
myocardiumUBERON:000234950.25gold quality
gastrocnemiusUBERON:000138848.58gold quality
nasal cavity epitheliumUBERON:000538447.03gold quality
muscle of legUBERON:000138345.82gold quality
subcutaneous adipose tissueUBERON:000219045.62gold quality
bone marrow cellCL:000209245.44gold quality
skeletal muscle tissueUBERON:000113445.35gold quality
esophagus mucosaUBERON:000246944.69gold quality
muscle tissueUBERON:000238544.65gold quality
heart left ventricleUBERON:000208444.24gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.62

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): ELF5

miRNA regulators (miRDB)

57 targeting KRT77, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-548AW99.9972.573559
HSA-MIR-428299.9975.366408
HSA-MIR-365899.9673.874379
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-1-3P99.9372.351914
HSA-MIR-20699.9372.501893
HSA-MIR-6768-5P99.9267.361942
HSA-MIR-548AZ-5P99.8369.943230
HSA-MIR-548T-5P99.8369.913220
HSA-MIR-465899.7764.94514
HSA-MIR-6790-5P99.7765.24505
HSA-MIR-3059-5P99.7069.932491
HSA-MIR-6892-3P99.6866.401178
HSA-MIR-3679-3P99.6469.881599
HSA-MIR-360999.5269.892587
HSA-MIR-548AH-5P99.5269.732626
HSA-MIR-642A-5P99.5165.101152
HSA-MIR-766-5P99.4767.912225
HSA-MIR-516A-3P99.4667.961378
HSA-MIR-516B-3P99.4667.961378
HSA-MIR-7162-5P99.4668.081368
HSA-MIR-361299.4566.021333
HSA-MIR-65099.4565.771309
HSA-MIR-94099.3766.142064
HSA-MIR-127299.3468.79878
HSA-MIR-6808-5P99.3166.232150
HSA-MIR-6893-5P99.3166.252119
HSA-MIR-548V99.2969.471157
HSA-MIR-324-3P99.2666.311034
HSA-MIR-569099.2567.581012

Literature-anchored findings (GeneRIF, showing 2)

  • Epithelial keratin, K1b, is exclusively expressed in luminal duct cells of eccrine sweat glands. (PMID:16117782)
  • Molecular Modeling of Pathogenic Mutations in the Keratin 1B Domain. (PMID:32927888)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusKrt77ENSMUSG00000067594
rattus_norvegicusKrt77ENSRNOG00000036865

Paralogs (68): KRT33A (ENSG00000006059), VIM (ENSG00000026025), KRT31 (ENSG00000094796), NEFM (ENSG00000104722), KRT23 (ENSG00000108244), KRT37 (ENSG00000108417), KRT32 (ENSG00000108759), KRT18 (ENSG00000111057), LMNB1 (ENSG00000113368), KRT36 (ENSG00000126337), KRT17 (ENSG00000128422), GFAP (ENSG00000131095), KRT34 (ENSG00000131737), KRT33B (ENSG00000131738), NES (ENSG00000132688), PRPH (ENSG00000135406), KRT85 (ENSG00000135443), KRT7 (ENSG00000135480), KRT71 (ENSG00000139648), INA (ENSG00000148798), LMNTD1 (ENSG00000152936), LMNA (ENSG00000160789), KRT84 (ENSG00000161849), KRT82 (ENSG00000161850), KRT80 (ENSG00000167767), KRT1 (ENSG00000167768), KRT24 (ENSG00000167916), KRT8 (ENSG00000170421), KRT78 (ENSG00000170423), KRT86 (ENSG00000170442), KRT75 (ENSG00000170454), KRT6C (ENSG00000170465), KRT4 (ENSG00000170477), KRT74 (ENSG00000170484), KRT72 (ENSG00000170486), KRT83 (ENSG00000170523), BFSP2 (ENSG00000170819), KRT19 (ENSG00000171345), KRT15 (ENSG00000171346), KRT38 (ENSG00000171360)

Protein

Protein identifiers

Keratin, type II cytoskeletal 1bQ7Z794 (reviewed: Q7Z794)

Alternative names: Cytokeratin-1B, Keratin-77, Type-II keratin Kb39

All UniProt accessions (2): Q7Z794, F8VS61

UniProt curated annotations — full annotation on UniProt →

Tissue specificity. Expressed exclusively in skin.

Post-translational modifications. Undergoes deimination of some arginine residues (citrullination).

Miscellaneous. There are two types of cytoskeletal and microfibrillar keratin: I (acidic; 40-55 kDa) and II (neutral to basic; 56-70 kDa).

Similarity. Belongs to the intermediate filament family.

RefSeq proteins (1): NP_778253* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003054Keratin_IIFamily
IPR018039IF_conservedConserved_site
IPR032444Keratin_2_headDomain
IPR039008IF_rod_domDomain

Pfam: PF00038, PF16208

UniProt features (18 total): region of interest 8, compositionally biased region 2, modified residue 2, sequence conflict 2, chain 1, domain 1, site 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q7Z794-F168.730.42

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 418 (stutter)

Post-translational modifications (2): 95, 523

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-6805567Keratinization
R-HSA-6809371Formation of the cornified envelope
R-HSA-1266738Developmental Biology

MSigDB gene sets: 56 (showing top): GOBP_EPITHELIUM_DEVELOPMENT, GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS, GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, MARTINEZ_RB1_TARGETS_UP, GATA6_01, GOBP_EPIDERMIS_DEVELOPMENT, GOBP_KERATINIZATION, GOBP_SKIN_DEVELOPMENT, MARTINEZ_RB1_AND_TP53_TARGETS_UP, CTAWWWATA_RSRFC4_Q2, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, GOCC_CORNIFIED_ENVELOPE, GOMF_STRUCTURAL_MOLECULE_ACTIVITY

GO Biological Process (2): keratinization (GO:0031424), intermediate filament organization (GO:0045109)

GO Molecular Function (2): structural constituent of skin epidermis (GO:0030280), protein binding (GO:0005515)

GO Cellular Component (6): cornified envelope (GO:0001533), cytosol (GO:0005829), cytoskeleton (GO:0005856), keratin filament (GO:0045095), extracellular exosome (GO:0070062), intermediate filament (GO:0005882)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Developmental Biology1
Keratinization1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
keratinocyte differentiation1
multicellular organismal process1
intermediate filament cytoskeleton organization1
supramolecular fiber organization1
structural molecule activity1
binding1
plasma membrane1
cytoplasm1
cellular anatomical structure1
intracellular membraneless organelle1
intermediate filament1
extracellular vesicle1
intermediate filament cytoskeleton1
polymeric cytoskeletal fiber1

Protein interactions and networks

STRING

926 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KRT77SPRR4Q96PI1474
KRT77KRTDAPP60985473
KRT77S100A7P31151467
KRT77KLK6Q92876457
KRT77S100A2P29034436
KRT77LCE2CQ5TA81425
KRT77KLK14Q9P0G3417
KRT77S100A12P80511414
KRT77ANXA1P04083411
KRT77TCHHL1Q5QJ38410
KRT77LARP1BQ659C4407
KRT77SERPINB13Q9UIV8406
KRT77SPRR2DP22532400
KRT77LCE2DQ5TA82400
KRT77LCE3CQ5T5A8396

IntAct

57 interactions, top by confidence:

ABTypeScore
KRT31KRT77psi-mi:“MI:0915”(physical association)0.560
KRT77MDFIpsi-mi:“MI:0915”(physical association)0.560
KRT19KRT77psi-mi:“MI:0915”(physical association)0.560
KRT27KRT77psi-mi:“MI:0915”(physical association)0.560
KRT77KRT35psi-mi:“MI:0915”(physical association)0.560
KRT15KRT77psi-mi:“MI:0915”(physical association)0.560
KRT36KRT77psi-mi:“MI:0915”(physical association)0.560
KRT17KRT77psi-mi:“MI:0915”(physical association)0.400
HERC2FTLpsi-mi:“MI:0914”(association)0.350
WTAPDDX39Apsi-mi:“MI:0914”(association)0.350
METTL14HMGB1P1psi-mi:“MI:0914”(association)0.350
DCUN1D1RGSL1psi-mi:“MI:0914”(association)0.350
CUL5DDX3Xpsi-mi:“MI:0914”(association)0.350
WWC1KRT6Bpsi-mi:“MI:0914”(association)0.350
YAP1TEAD1psi-mi:“MI:0914”(association)0.350
CLIC1psi-mi:“MI:0914”(association)0.350
CFTRPOTEFpsi-mi:“MI:0914”(association)0.350
BMI1MEIS3P1psi-mi:“MI:0914”(association)0.350
RYBPPIPSLpsi-mi:“MI:0914”(association)0.350
MAP1LC3Bpsi-mi:“MI:0914”(association)0.350
GABARAPL2psi-mi:“MI:0914”(association)0.350
GABARAPL1psi-mi:“MI:0914”(association)0.350
ATG101FOXO3psi-mi:“MI:0914”(association)0.350
CACNA1CIGLL5psi-mi:“MI:0914”(association)0.350
SMIM26METTL15psi-mi:“MI:0914”(association)0.350
SULF2IGLL5psi-mi:“MI:0914”(association)0.350
SULF2IGKV2-29psi-mi:“MI:0914”(association)0.350
SULF2HNRNPCL1psi-mi:“MI:0914”(association)0.350
SULF2IGHA1psi-mi:“MI:0914”(association)0.350
LGALS3BPIGHV3-64Dpsi-mi:“MI:0914”(association)0.350

BioGRID (96): KRT77 (Two-hybrid), KRT77 (Two-hybrid), KRT77 (Affinity Capture-MS), KRT77 (Co-fractionation), KRT77 (Co-fractionation), KRT77 (Co-fractionation), KRT77 (Affinity Capture-MS), KRT77 (Affinity Capture-MS), KRT77 (Affinity Capture-MS), KRT77 (Affinity Capture-MS), KRT77 (Affinity Capture-MS), KRT77 (Affinity Capture-MS), KRT77 (Affinity Capture-MS), KRT77 (Affinity Capture-MS), KRT77 (Affinity Capture-MS)

ESM2 similar proteins: A0JND2, A3KN27, A5A6N0, A6BLY7, A6H712, A6QNX5, A7YWK3, E1AB55, P07744, P08729, P19013, P25691, Q0P5J4, Q0P5J6, Q0P5J7, Q0VBK2, Q148H5, Q148H6, Q148H7, Q148H8, Q14CN4, Q3SY84, Q5XKE5, Q64291, Q6IFW8, Q6IFZ9, Q6IG00, Q6IG01, Q6IG03, Q6IG04, Q6IME9, Q6IMF0, Q6IMF1, Q6KB66, Q6NXH9, Q6R649, Q7RTS7, Q7Z3Y7, Q7Z3Y9, Q7Z794

Diamond homologs: A0A125S9M6, A0JND2, A4FUZ0, A5A6M8, A6NCN2, A7YWK3, O43790, P02542, P02545, P02547, P02548, P04104, P04260, P04261, P04262, P04263, P07196, P07744, P08551, P08928, P09010, P10999, P12035, P12036, P13647, P13648, P15241, P16884, P19013, P19246, P19527, P21619, P21910, P25691, P35908, P48671, P48672, P48678, P48679, P78385

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 61 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Formation of the cornified envelope819.0×2e-06
Keratinization812.0×3e-05

GO biological processes:

GO termPartnersFoldFDR
morphogenesis of an epithelium751.2×1e-08
intermediate filament organization841.0×6e-09
epithelial cell differentiation726.1×1e-06

Disease & clinical

Clinical variants and AI predictions

ClinVar

103 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance91
Likely benign9
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1275 predictions. Top by Δscore:

VariantEffectΔscore
12:52691437:CGG:Cacceptor_gain1.0000
12:52691440:C:CCacceptor_gain1.0000
12:52691936:A:ACdonor_gain1.0000
12:52691937:C:CCdonor_gain1.0000
12:52692417:CCA:Cdonor_loss1.0000
12:52692418:CA:Cdonor_loss1.0000
12:52692420:CCTG:Cdonor_gain1.0000
12:52692427:T:Adonor_gain1.0000
12:52692648:C:CTacceptor_gain1.0000
12:52692881:C:CCacceptor_gain1.0000
12:52692888:C:CTacceptor_gain1.0000
12:52692889:A:Tacceptor_gain1.0000
12:52694622:CCACC:Cdonor_loss1.0000
12:52694623:CACCT:Cdonor_loss1.0000
12:52694624:ACCT:Adonor_loss1.0000
12:52694625:C:Adonor_loss1.0000
12:52694654:T:TAdonor_gain1.0000
12:52696364:CCTCA:Cdonor_loss1.0000
12:52696365:CTCA:Cdonor_loss1.0000
12:52696366:TCAC:Tdonor_loss1.0000
12:52696367:CACCT:Cdonor_loss1.0000
12:52696368:ACCT:Adonor_loss1.0000
12:52697654:C:Adonor_gain1.0000
12:52697680:A:ACdonor_gain1.0000
12:52697681:C:CAdonor_gain1.0000
12:52697681:CTTG:Cdonor_gain1.0000
12:52697706:T:TAdonor_gain1.0000
12:52702887:CTCA:Cdonor_loss1.0000
12:52702888:TCACC:Tdonor_loss1.0000
12:52702889:CACCT:Cdonor_loss1.0000

AlphaMissense

3790 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:52702910:A:CF175L0.989
12:52702910:A:TF175L0.989
12:52702912:A:GF175L0.989
12:52696373:C:AK272N0.988
12:52696373:C:GK272N0.988
12:52694649:C:GA353P0.982
12:52702911:A:CF175C0.977
12:52702911:A:GF175S0.976
12:52692870:A:GL364P0.975
12:52697856:T:AK195I0.974
12:52692807:A:GL385P0.971
12:52697877:T:GQ188P0.970
12:52702920:T:AN172I0.970
12:52692611:C:GA413P0.963
12:52694690:C:GR339P0.963
12:52692859:C:GA368P0.961
12:52696385:A:CF268L0.960
12:52696385:A:TF268L0.960
12:52696387:A:GF268L0.960
12:52697775:A:GL222P0.959
12:52702901:G:CF178L0.958
12:52702901:G:TF178L0.958
12:52702903:A:GF178L0.958
12:52697855:T:AK195N0.955
12:52697855:T:GK195N0.955
12:52702919:G:CN172K0.955
12:52702919:G:TN172K0.955
12:52696377:A:GL271P0.953
12:52697880:T:GQ187P0.953
12:52702908:G:TA176D0.953

dbSNP variants (sampled 300 via entrez): RS1000048299 (12:52698222 G>A,T), RS1000141410 (12:52697950 C>A,G), RS1000999236 (12:52692107 A>G), RS1001188245 (12:52702455 T>C), RS1001862973 (12:52693757 T>C), RS1001954129 (12:52695126 C>A,T), RS1002172113 (12:52690762 G>T), RS1002347221 (12:52696946 C>T), RS1002392829 (12:52699497 C>T), RS1002399069 (12:52693494 T>C), RS1002457104 (12:52705226 T>C), RS1002504224 (12:52689404 GAGAAGA>G,GAGA,GAGAAGAAGA), RS1002553550 (12:52696516 T>C), RS1002812662 (12:52701072 C>A,T), RS1002863693 (12:52701329 C>T)

Disease associations

OMIM: gene MIM:611158 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

17 total (human), top 17 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression2
Nickeldecreases expression2
sodium arsenatedecreases expression, increases abundance1
pyrogallol 1,3-dimethyl etherdecreases expression, affects cotreatment, affects localization1
butyraldehydeincreases expression1
epigallocatechin gallateincreases expression1
pentanalincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideincreases expression1
bromovanindecreases expression1
Arsenicdecreases expression, increases abundance1
Benzo(a)pyreneincreases methylation1
Furaldehydeaffects localization, increases expression, affects cotreatment1
Sodium Chlorideaffects cotreatment, affects localization, increases expression, decreases expression1
Tetrachlorodibenzodioxindecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Triclosandecreases expression1
Aflatoxin B1increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.